期刊文献+

左室舒张末压对舒张性心力衰竭患者预后的预测价值 被引量:3

Predictive value of left ventricular end-diastolic pressure in patients with diastolic heart failure
原文传递
导出
摘要 目的:评价左室舒张末压(LVEDP)对舒张性心力衰竭(心衰)患者的预后预测价值。方法:使用左心导管测定舒张性心衰患者的LVEDP,并进行随访。根据随访结果比较无心源性事件组和心源性复合终点事件组的LVEDP水平;通过患者的ROC曲线划分有无心源性事件发生的最佳阈值点,根据该阈值点划分2组并运用KaPlan-Meier法分析其生存率;采用多因素COX回归分析法。结果:171例患者平均随访(15.70±3.43)个月,心源性复合终点事件组的LVEDP水平为17.5(9.4,20.1)mmHg,显著高于无心源性事件组的12.5(7.4,16.3)mmHg(P=0.032)。根据ROC曲线,LVEDP15.1mmHg为划分有无心源性事件发生的最佳阈值点,LVEDP<15.1mmHg的患者无心源性事件生存时间约是LVEDP>15.1mmHg患者的1.32倍(16.46个月∶12.43个月,P=0.007)。COX多元回归分析发现,LVEDP和BNP是心脏复合终点事件的独立相关影响因素,其中又以LVEDP的相关性更强。结论:LVEDP对舒张性心衰患者的预后预测价值好,LVEDP和BNP是心脏复合终点事件的独立相关影响因素。 Objective:To evaluate the predictive value of left ventricular end-diastolic pressure (LVEDP) for patients with diastolic heart failure (DHF). Method:LVEDP in patients with DHF was examined by left cardiac catheter. Cardiac composite end point events were cardiac death and re-admission. According to the follow-up results, we compared LVEDP levels of cardiac composite end point events group with non-cardiac composite end point events group, and searched for the cut off point by ROC. According to the cut off point about LVEDP level, all the patients were divided into two groups and used KaPlan-Meier method to analysis survival rates. Cox regression analysis was performed to assess the factors that affecting cardiac composite end point events. Result:A total of 171 patients were followed up (15.70±3.43)months. The LVEDP level in cardiac composite end point events group [17.5(9.4, 20.1)mmHg, 1 mmHg=0.133 kPa] was higher than that in non-cardiac composite end point events group [12.5(7.4, 16.3)mmHg] (P=0.032). The cut off point of LVEDP level was 15.1 mmHg. Multivariate Cox analysis ahowed that LVEDP and BNP remained as the significant predictors of cardiac events, especially LogLVEDP. Conclusion:LVEDP has good predictive value for the clinical prognosis of patients with DHF. LVEDP and BNP are independent influencing factors for the cardiac composite end point events.
出处 《临床心血管病杂志》 CAS CSCD 北大核心 2013年第6期429-432,共4页 Journal of Clinical Cardiology
关键词 心力衰竭 舒张性 左室舒张末压 预后 heart failure diastolic left ventricular end-diastolic pressure prognosis
  • 相关文献

参考文献9

  • 1MCMURRAY J J,ADAMOPOULOS S,ANKER S D,et al.ESC guidelines for the diagnosis and treat-ment of acute and chronic heart failure2012[J].Eur J Heart Fail,2012,14:803-869.
  • 2ROGERS R K,MAY H T,ANDERSON J L,et al.Prognostic value of B-type natriuretic peptide for car-diovascular events independent of left ventricular end-diastolic pressure[J].Am Heart J,2009,158:777-783.
  • 3PLANER D,MEHRAN R,WITZENBICHLER B,et al.Prognostic utility of left ventricular end-dias-tolic pressure in patients with ST-segment elevation myocardial infarction undergoing primary percutane-ous coronary intervention[J].Am J Cardiol,2011,15,108:1068-1074.
  • 4MIELNICZUK L M,LAMAS G A,FLAKER G C,et al.Left ventricular end-diastolic pressure and risk of subsequent heart failure in patients following an a-cute myocardial infarction[J].Congest Heart Fail,2007,13:209-214.
  • 5TEIXEIRA R,LOURENO C,BAPTISTA R,et al.Prognostic implications of left ventricular end-dias-tolic pressure in acute coronary syndromes with left ventricular ejection fraction of40%or over[J].Rev Port Cardiol,2011,30:771-779.
  • 6张政.扩张型心肌病患者血清B型利钠肽浓度与心功能及预后的关系[J].临床荟萃,2009,24(15):1329-1330. 被引量:4
  • 7STOLKER J M,RICH M W.Clinical utility of B-type natriuretic peptide for estimating left ventricular filling pressures in unselected elderly patients under-going diagnostic coronary angiography[J].J Invasive Cardiol,2010,22:107-112.
  • 8陈炼,朱伟达,楼丽娜,沈菁原,倪琦.BNP对判断心力衰竭严重程度及其预后的价值[J].苏州大学学报(医学版),2006,26(4):640-641. 被引量:17
  • 9DANIELS L B,MAISEL A S.Natriuretic peptides[J].J Am Coll Cardiol,2007,18,50:2357-2368.

二级参考文献20

  • 1郭攀,黄振文,卢长青.B型钠尿肽与心功能不全严重程度及近期愈后的关系探讨[J].河南医学研究,2005,14(3):208-210. 被引量:7
  • 2林营.心力衰竭患者BNP的临床价值[J].海南医学院学报,2005,11(6):512-514. 被引量:4
  • 3朱红俊,龚少愚,邹逊,魏慧渊,陆曙.心力衰竭病因对血浆BNP水平的影响[J].临床荟萃,2007,22(1):27-28. 被引量:25
  • 4张拥军,郭静霞,郭丽.脑钠肽临床应用研究进展[J].临床荟萃,2007,22(8):601-603. 被引量:11
  • 5陆再英,钟南山.内科学[M].7版.北京:人民卫生出版社,2008:35-38.
  • 6Ishii J, Nomura M, Nakamura Y,et al. Risk stratification using a combination of cardiac troponin T and brain natriuretic peptide in patients hospitalized for worsening chronic heart failure[J]. Am J Cardiol,2002,89(2) :691-695.
  • 7Davis M, Espiner E oRichards G, et al. Plasma brain natriuretie peptide in assessment of acute dyspnea[J]. Lancet, 1994,343 (8895) : 440-444.
  • 8Chen HH, Burnett JC. Natriuretic peptides in the pathophysiology of congestive heart failure[J]. Curr Cardiol Rep. 2000,2(3) : 198-205.
  • 9Wieczorek SJ, Wu AH, Christenson R, et al. A rapid B-type natriuretic peptide assay accurately diagnoses left ventuicular dysfunction and heart failure :a multicenter evaluation[J]. Am Heart,2002,144(5) :834-839.
  • 10Sagnella GA. Measurement and significance of circulating natriuretic peptides in cardiovascular disease[J]. Clin Sci, 1998,95(5) :519-529.

共引文献19

同被引文献25

引证文献3

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部